Mohammad Farah, Kabbani Loay, Lin Judith, Karamanos Efstathios, Esmael Fatema, Shepard Alexander
Division of General and Vascular Surgery, Department of Surgery, Henry Ford Hospital, Detroit, MI, USA.
Vascular. 2017 Apr;25(2):178-183. doi: 10.1177/1708538116654837. Epub 2016 Jul 9.
Objectives Pseudoaneurysms are a well-recognized complication of percutaneous angiographic procedures. Ultrasound-guided thrombin injection is currently the preferred treatment modality. This study was undertaken to evaluate our experience with the management of post-procedure pseudoaneurysms. Methods A retrospective study was undertaken of all patients who developed a post-procedure pseudoaneurysm between March 2004 and January 2013. Data were obtained from our prospectively maintained non-invasive vascular laboratory data base. Results Overall, 167 patients (80 men) with post-procedure pseudoaneurysms were identified. The mean age was 66 years. Post-procedure pseudoaneurysms developed following diagnostic coronary angiography (38%), coronary angioplasty (37%), peripheral vascular interventions (14.7%), or other access procedures (7.6%). Mean post-procedure pseudoaneurysm diameter was 2.8 ± 1.8 cm. One hundred forty-two post-procedure pseudoaneurysms were injected with thrombin under ultrasound guidance. Primary success rate was 93.5%. There were 12 (8.5%) procedural failures of which seven (58%) responded to reinjection, three (25%) required operative management, one was treated with ultrasound-guided compression, and one (8.3%) was simply observed. On multivariate analysis, failures were associated with increased aneurysm diameter ( p = 0.006; odds ratio 2.23, 95% CI 1.25 to 3.96), end-stage renal disease ( p = 0.013; odds ratio 1.15, 95% CI 1.09 to 1.78) and superficial femoral artery aneurysm origin ( p = 0.031; odds ratio 0.20, 95% CI 0.04 to 0.86). There were two episodes of thrombus formation in the femoral artery; one resolved with anticoagulation alone, and the other required thrombectomy. Conclusions Percutaneous ultrasound-guided thrombin injection is an effective and safe method for managing post-procedure pseudoaneurysms. Failure rates are low and associated with large aneurysm size, superficial femoral artery origin and end-stage renal disease.
目的 假性动脉瘤是经皮血管造影术公认的一种并发症。超声引导下注射凝血酶是目前首选的治疗方式。本研究旨在评估我们处理术后假性动脉瘤的经验。方法 对2004年3月至2013年1月期间所有发生术后假性动脉瘤的患者进行回顾性研究。数据来自我们前瞻性维护的非侵入性血管实验室数据库。结果 总体上,共识别出167例(80例男性)术后假性动脉瘤患者。平均年龄为66岁。术后假性动脉瘤在诊断性冠状动脉造影后发生(38%)、冠状动脉成形术后发生(37%)、外周血管介入术后发生(14.7%)或其他穿刺术后发生(7.6%)。术后假性动脉瘤平均直径为2.8±1.8 cm。142例术后假性动脉瘤在超声引导下注射凝血酶。一次成功率为93.5%。有12例(8.5%)操作失败,其中7例(58%)再次注射有效,3例(25%)需要手术处理,1例采用超声引导下压迫治疗,1例(8.3%)仅进行观察。多因素分析显示,失败与动脉瘤直径增大(p = 0.006;比值比2.23,95%可信区间1.25至3.96)、终末期肾病(p = 0.013;比值比1.15,95%可信区间1.09至1.78)以及股浅动脉动脉瘤起源(p = 0.031;比值比0.20,95%可信区间0.04至0.86)相关。股动脉有2次血栓形成事件;1次仅通过抗凝治疗得以缓解,另1次需要进行血栓切除术。结论 经皮超声引导下注射凝血酶是处理术后假性动脉瘤的一种有效且安全的方法。失败率较低,且与动脉瘤尺寸较大、股浅动脉起源以及终末期肾病相关。